SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-21-000048
Filing Date
2021-08-09
Accepted
2021-08-09 16:36:58
Documents
96
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20210630x10q.htm   iXBRL 10-Q 2908105
2 EX-10.1 amph-20210630ex101104982.htm EX-10.1 29475
3 EX-10.2 amph-20210630ex102abeb21.htm EX-10.2 263030
4 EX-10.3 amph-20210630ex103599649.htm EX-10.3 375653
5 EX-31.1 amph-20210630ex31180228a.htm EX-31.1 18647
6 EX-31.2 amph-20210630ex312f864ee.htm EX-31.2 18302
7 EX-32.1 amph-20210630ex3215b52b9.htm EX-32.1 9567
8 EX-32.2 amph-20210630ex322cfcf58.htm EX-32.2 9568
  Complete submission text file 0001297184-21-000048.txt   12183749

Data Files

Seq Description Document Type Size
9 EX-101.SCH amph-20210630.xsd EX-101.SCH 66539
10 EX-101.CAL amph-20210630_cal.xml EX-101.CAL 65782
11 EX-101.DEF amph-20210630_def.xml EX-101.DEF 256519
12 EX-101.LAB amph-20210630_lab.xml EX-101.LAB 521500
13 EX-101.PRE amph-20210630_pre.xml EX-101.PRE 475396
14 EXTRACTED XBRL INSTANCE DOCUMENT amph-20210630x10q_htm.xml XML 2487218
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 211157053
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences